[1] ARBNU M,WALKER A,MEIJER C J.HPV-based cervical-cancer screening in China[J]. Lancet Oncol,2010,11(12):1112-1113. [2] BURCHELL A N,WINER R L,DE SANJOSE S,et al.Chapter 6:Epidemiology and transmission dynamics of genital HPV infection[J].Vaccine,2006,24(S3):52-61. [3] MUNOZ N,BOSCH F X,DE SANJOSE S,et al.Epidemiologic classification of human papillomavirus types associated with cervical cancer[J].N Engl J Med,2003,348(6):518-527. [4] BRUNI L,DIAZ M,CASTELLSAGUE X,et al.Cervical human papillomavirus prevalence in 5 continents:meta-analysis of 1 million women with normal cytological findings[J]. J Infect Dis,2010, 202(12):1789-1799. [5] BRAY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2018,68(6):394-424. [6] CROW J M.HPV:the global burden[J]. Nature,2012,488:2-3. [7] 吴云燕,裘明利. 女性高危型人乳头瘤病毒感染分布情况研究[J]. 中国实用妇科与产科杂志,2017,9(1):122-124. [8] 鄢春晖,陈林,袁蔓莉,等. 重庆地区12 196例妇科门诊患者HPV亚型感染情况分析[J]. 重庆医学,2014,21(35):4746-4748. [9] 张胜,李凌佳,王杨,等. 门诊疑似患者人乳头瘤病毒检测及基因亚型分布[J]. 中国皮肤性病学杂志,2016,15(10):1033-1036. [10] HUANG S,AFONINA I,MILLER B A,et al.Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women[J]. Int J Cancer,1997,70(4):408-411. [11] LIU J,ROSE B,HUANG X,et al.Comparative analysis of characteristics of women with cervical cancer in high-versus low-incidence regions[J]. Gynecol Oncol,2004,94(3):803-810. [12] BALOCH Z,LI Y,YUAN T,et al.Epidemiologic characterization of human papillomavirus(HPV)infection in various regions of Yunnan Province of China[J]. BMC Infect Dis,2016,16(1):228. [13] TANG Y,ZHENG L,YANG S,et al.Epidemiology and genotype distribution of human papillomavirus(HPV)in Southwest China:a cross-sectional five years study in non-vaccinated women[J]. Virol J,2017,14(1):84. [14] AGENIS A,DUFIT V,DOUINE M,et al.High prevalence of HPV infection in the remote villages of French Guiana:an epidemiological study[J]. Epidemiol Infect,2017,145(6):1276-1284. [15] LYNGE E,CLAUSEN L B,GUIGNARD R,et al.What happens when organization of cervical cancer screening is delayed or stopped[J]. J Med Screen,2006,13(1):41-46. |